Neurally adjusted ventilatory assist vs pressure support ventilation: short-term effects on shunt and dead space after cardiac surgery

Postoperative pulmonary complications, particularly atelectasis, are common after cardiac surgery and may contribute to impaired gas exchange or acute lung injury (ALI). Neurally Adjusted Ventilatory Assist (NAVA) delivers ventilatory support proportional to the patient's respiratory drive, offering theoretical advantages over Pressure Support Ventilation (PSV), including improved synchrony, enhanced diaphragmatic efficiency, and reduced risk of ventilator-induced lung injury. However, comparative data on gas exchange, dead space, and regional ventilation during weaning after cardiac surgery remain limited. This prospective crossover study evaluated 12 mechanically ventilated patients with mild ALI following cardiac surgery across three ventilation phases: two PSV phases (PSV1 and PSV2) separated by a phase of NAVA. Intrapulmonary shunt fraction was calculated from measurements obtained via a Swan-Ganz catheter. Physiological dead space fraction (V<sub>D</sub>/V<sub>T</sub>) was assessed using three methods: the Bohr-Enghoff equation, end-tidal CO₂-derived alveolar dead space fraction (AVDSf-ET), and a novel time-to-volume converted capnographic approach (V<sub>CAP-CALC</sub>). Regional ventilation was assessed using electrical impedance tomography (EIT), and neuroventilatory efficiency (NVE) was calculated from diaphragmatic electrical activity (EAdi). Data were analyzed using linear mixed-effects models to account for repeated measures and within-subject variability. V<sub>D</sub>/V<sub>T</sub> was significantly lower during NAVA compared with PSV1 and PSV2 when assessed by V<sub>CAP-CALC</sub> (58.5% vs. 63.8% and 61.3%, respectively; p < 0.001). The PaO₂/FiO₂ ratio and NVE were significantly higher during NAVA (p = 0.01 and p = 0.037, respectively). No significant difference in pulmonary shunt fraction was observed. EIT revealed a modest increase in dorsal end-expiratory lung volume during NAVA, without redistribution of tidal volume or Center of Ventilation. The V<sub>CAP-CALC</sub> method showed strong agreement with established dead space measures (R2 = 0.77-0.82) and demonstrated high repeatability (mean coefficient of variation 3.5%). NAVA is a safe and feasible ventilatory mode following cardiac surgery, associated with reduced dead space fraction, improved oxygenation and enhanced neuroventilatory efficiency. Given that shunt fraction remained unchanged, the observed improvement in ventilation-perfusion (V/Q) matching reflects a reduction in V<sub>D</sub>/V<sub>T</sub>. The potential implications for postoperative recovery and long-term outcomes merit evaluation in larger clinical studies.ClinicalTrials.gov: NCT03217305. Initial Release 21/06/2017.

Institutions

Publication Details

Journal
Scientific Reports
Published
2025-12-21
DOI
https://doi.org/10.1038/s41598-025-33097-1
Primary Topic
Respiratory Support and Mechanisms
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Neurally adjusted ventilatory assist vs pressure support ventilation: short-term effects on shunt and dead space after cardiac surgery

Scientific Reports
Respiratory Support and Mechanisms
article

Neurally adjusted ventilatory assist vs pressure support ventilation: short-term effects on shunt and dead space after cardiac surgery

article en

Abstract

Postoperative pulmonary complications, particularly atelectasis, are common after cardiac surgery and may contribute to impaired gas exchange or acute lung injury (ALI). Neurally Adjusted Ventilatory Assist (NAVA) delivers ventilatory support proportional to the patient's respiratory drive, offering theoretical advantages over Pressure Support Ventilation (PSV), including improved synchrony, enhanced diaphragmatic efficiency, and reduced risk of ventilator-induced lung injury. However, comparative data on gas exchange, dead space, and regional ventilation during weaning after cardiac surgery remain limited. This prospective crossover study evaluated 12 mechanically ventilated patients with mild ALI following cardiac surgery across three ventilation phases: two PSV phases (PSV1 and PSV2) separated by a phase of NAVA. Intrapulmonary shunt fraction was calculated from measurements obtained via a Swan-Ganz catheter. Physiological dead space fraction (V<sub>D</sub>/V<sub>T</sub>) was assessed using three methods: the Bohr-Enghoff equation, end-tidal CO₂-derived alveolar dead space fraction (AVDSf-ET), and a novel time-to-volume converted capnographic approach (V<sub>CAP-CALC</sub>). Regional ventilation was assessed using electrical impedance tomography (EIT), and neuroventilatory efficiency (NVE) was calculated from diaphragmatic electrical activity (EAdi). Data were analyzed using linear mixed-effects models to account for repeated measures and within-subject variability. V<sub>D</sub>/V<sub>T</sub> was significantly lower during NAVA compared with PSV1 and PSV2 when assessed by V<sub>CAP-CALC</sub> (58.5% vs. 63.8% and 61.3%, respectively; p < 0.001). The PaO₂/FiO₂ ratio and NVE were significantly higher during NAVA (p = 0.01 and p = 0.037, respectively). No significant difference in pulmonary shunt fraction was observed. EIT revealed a modest increase in dorsal end-expiratory lung volume during NAVA, without redistribution of tidal volume or Center of Ventilation. The V<sub>CAP-CALC</sub> method showed strong agreement with established dead space measures (R2 = 0.77-0.82) and demonstrated high repeatability (mean coefficient of variation 3.5%). NAVA is a safe and feasible ventilatory mode following cardiac surgery, associated with reduced dead space fraction, improved oxygenation and enhanced neuroventilatory efficiency. Given that shunt fraction remained unchanged, the observed improvement in ventilation-perfusion (V/Q) matching reflects a reduction in V<sub>D</sub>/V<sub>T</sub>. The potential implications for postoperative recovery and long-term outcomes merit evaluation in larger clinical studies.ClinicalTrials.gov: NCT03217305. Initial Release 21/06/2017.

Scientific ReportsVol. 15(1)
Sahlgrenska University Hospital (SE), University of Gothenburg (SE), Umeå University (SE)
Hjärt-Lungfonden, Sahlgrenska Universitetssjukhuset
Openalex Percentile: Top 40%
Respiratory Support and Mechanisms
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.